Ultrasound has gained traction as more portable and less expensive diagnostic imaging tool, as compared to CT and MRI. However, several limitations are associated with the technology such as lengthy test durations, dependence on skill & expertise of operator. In a bid to resolve these concerns, prominent companies such as SonoCine, U-Systems, Inc., and Siemens Healthcare, have developed automated breast ultrasound system (ABUS), which utilizes high-frequency sound waves to provide the physicians with 3D volumetric image. Such 3D images are more beneficial for women with dense breast tissues, as they enable radiologists to examine the breast cancers from various angles and deliver a better interpretation. Moreover, the operator dependency is drastically reduced, as transducer employed in ABUS scans the breast automatically.
Key Takeaways from Fact.MR’s Report on Automated Breast Ultrasound System Market
Request For Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=585
Breast cancer has prevailed as most commonly diagnosed cancer type, and has become the second leading cause of mortality among women, according to statistics unveiled by National Breast Cancer Foundation. With growing awareness about breast cancer, number of screening procedures has proliferated, thereby propelling demand for advanced diagnostic and follow-up care technologies such as automated breast ultrasound systems in diagnostic centers and hospitals. Facilitated screening of denser breast’s tissues, along with the provision of superior image quality, has offered automated breast ultrasound system (ABUS) a competitive edge over the handheld ultrasound system (HHUS).
As automated breast ultrasound system are approved by the FDA for screening in coordination with mammography, in case of women with denser breast tissues, radiologists are increasingly opting for the technology. On the back of high quality 3D images offered by ABUS, surgeons are employing the system for pre-operative breast evaluation to identify tumor size and location accurately. However, high cost, and lack of skilled radiologists needed for ABUS have made surgeons to opt for HHUS for pre-operative evaluation.
Governments across the globe are launching awareness campaigns for encouraging women with breast cancer to take professional help and undergo diagnosis. Public Health England, for example, launched a campaign – Be Clear on Cancer’ in 2015 for raising awareness on breast cancer among women over seventy years old. In addition, the Breast Cancer Now Catalyst Programme encouraged and offered tremendous support to research and development in diagnosis and treatment of breast cancer. Awareness campaigns on breast cancer are further expected to influence demand for automated breast ultrasound system.
Fact.MR’s report has identified key players underpinning expansion of the global automated breast ultrasound system market, which include GE Healthcare, Delphinus Medical Technologies, Inc., Siemens AG, SonoCine Inc., and Hitachi, Ltd. Product innovation will continue to be a key strategy among the market players to gain a competitive edge. A breakthrough innovation, called “Automated Breast Volume Scanner (ABVS)” has been recently introduced by Siemens Healthcare, which provides volume images of breasts, and helps in exhaustive screening using ultrasound.
View Full Report with TOC @ https://www.factmr.com/report/585/automated-breast-ultrasound-system-market
Table of Content:
Buy This Report @ https://www.factmr.com/checkout/585/S